Earnings
MGTA
8.47
+0.89%
0.08
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
65.07M
80.66M
--
--
--
--
0.00
--
--
--
4.11M
--
149.84M
9.89M
--
--
--
--
--
--
1.78M
11.67M
161.51M
--
2.81M
0.00
--
--
--
--
--
10.70M
--
--
--
601.00K
14.12M
0.00
--
--
--
6.21M
6.21M
20.32M
39.00K
320.64M
-179.50M
--
--
--
141.19M
141.19M
161.51M
FY 2018-12-31
58.34M
84.22M
--
--
--
--
0.00
--
--
--
2.75M
0.00
145.32M
10.21M
--
--
--
--
--
--
1.78M
11.99M
157.31M
--
3.49M
0.00
--
--
--
--
--
6.93M
--
--
--
--
10.42M
0.00
--
--
--
1.25M
1.25M
11.66M
33.00K
248.35M
-102.73M
--
--
--
145.65M
145.65M
157.31M
FY 2017-12-31
51.40M
--
--
--
--
--
0.00
--
--
--
936.00K
165.00K
52.50M
1.96M
--
--
--
--
--
--
4000.00
1.96M
54.46M
--
167.00K
0.00
--
--
--
--
--
3.98M
--
--
--
--
4.14M
0.00
--
--
--
--
0.00
4.14M
2000.00
3.09M
-45.21M
--
--
--
50.32M
-42.12M
54.46M
FY 2016-12-31
4.51M
--
--
--
--
--
6.25M
--
--
--
41.00K
30.00K
10.83M
508.00K
--
--
--
--
--
--
0.00
508.00K
11.34M
--
1.67M
0.00
--
--
--
--
--
633.00K
--
--
--
--
2.30M
0.00
--
--
--
--
0.00
2.30M
1000.00
845.00K
-9.72M
--
--
--
9.04M
9.04M
11.34M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out MGTA latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Magenta Therapeutics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.